https://www.marketscreener.com/quote/stock/PLUS-THERAPEUTICS-INC-64156491/news/Plus-Therapeutics-Inc-Initiates-Part-B-of-ReSPECT-LM-Phase-1-2a-Trial-for-Leptomeningeal-Metastase-44772103/?utm_source=telegram&utm_medium=social&utm_campaign=share